Clinical Trial Update: Safety and Efficacy of the GORE® Septal Occluder to Treat Ostium Secundum Atrial Septal Defects [NA]

View source ↗

Summary

Clinical trial results for the GORE Septal Occluder in treating ostium secundum atrial septal defects have been completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Septal Defect

Drugs mentioned

• GORE Septal Occluder (Septal occluder device)

Snippet

Sponsor: W.L.Gore & Associates | Conditions: Septal Defect, Atrial | NA | Status: COMPLETED | Results posted: 2020-08-21